US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Axsome Therapeutics

102.89

+1.291.27%

Volume:650.45K

Turnover:66.78M

Market Cap:5.08B

PE:-17.83

High:103.83

Open:101.13

Low:100.00

Close:101.60

Loading ...

Overview Company News Filings

Axsome Therapeutics announces FOCUS Phase 3 trial achieved primary endpoint

Axsome Therapeutics’ Promising Phase III FOCUS Trial Results Boost Buy Rating

Axsome Therapeutics' Phase 3 Trial of Solriamfetol to Treat ADHD Meets Primary Endpoint

MT Newswires Live

BRIEF-Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint

Axsome Therapeutics' ADHD drug meets main goal in late-stage study

Axsome Therapeutics Inc: Well Tolerated With Safety Profile Generally Consistent With Prior Solriamfetol Trials

THOMSON REUTERS

Axsome Therapeutics Announces Focus Phase 3 Trial of Solriamfetol in Adults With Attention Deficit Hyperactivity Disorder (Adhd) Achieves Primary Endpoint

THOMSON REUTERS

Axsome Therapeutics Inc: Statistically Significant Reduction in Overall Adhd Disease Severity as Measured by CGI-S Score Compared to Placebo

THOMSON REUTERS

Strong Growth and Positive Outlook for Axsome Therapeutics’ Auvelity Drives Buy Rating

Strong Market Performance and Growth Potential of Auvelity Drives Positive Outlook for Axsome Therapeutics

HRMY Down 10.8% in Six Months: How Should You Play the Stock?

Axsome Therapeutics' (NASDAQ:AXSM) growing losses don't faze investors as the stock rises 5.8% this past week

Simply Wall St.

Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?

Is Axsome Therapeutics, Inc. (AXSM) the Best Performing Growth Stock in 2025?

AXSM Settles Sunosi Patent Litigation With Hikma Pharmaceuticals

TD Cowen Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)

Axsome Therapeutics Price Target Maintained With a $200.00/Share by HC Wainwright & Co.

Axsome Therapeutics: Strategic Developments and Market Exclusivity Drive Buy Rating

Axsome Therapeutics management to meet with Piper Sandler

Axsome Therapeutics Resolves Sunosi Patent Case With Hikma

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AXSM/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AXSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXSM\",,,,,undefined,":{"symbol":"AXSM","market":"US","secType":"STK","nameCN":"Axsome Therapeutics","latestPrice":102.89,"timestamp":1750276800000,"preClose":101.6,"halted":0,"volume":650454,"delay":0,"floatShares":38424988,"shares":49376365,"eps":-5.769904,"marketStatus":"Pre-Mkt","change":1.29,"latestTime":"06-20 07:19:03 EDT","open":101.13,"high":103.83,"low":100,"amount":66776628.85278,"amplitude":0.037697,"askPrice":108.87,"askSize":8,"bidPrice":97.5,"bidSize":30,"shortable":3,"etf":0,"ttmEps":-5.769904,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1750426200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1447909200000,"exchange":"NASDAQ","adjPreClose":102.89,"postHourTrading":{"tag":"盘后","latestPrice":102.89,"preClose":102.89,"latestTime":"19:31 EDT","volume":81047,"amount":8322086.32,"timestamp":1750289465863},"volumeRatio":1.071842767136725,"impliedVol":0.3249,"impliedVolPercentile":0.0281},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXSM\",,,,,undefined,":{"symbol":"AXSM","floatShares":38424988,"roa":"-26.18%","roe":"-282.16%","lyrEps":-5.994374,"volumeRatio":1.071842767136725,"shares":49376365,"dividePrice":0,"high":103.83,"amplitude":0.037697,"preClose":101.6,"low":100,"week52Low":72.02,"pbRate":"95.49","psRate":"11.76","week52High":139.1299,"institutionHeld":0,"latestPrice":102.89,"committee":0.578947,"eps":-5.769904,"divideRate":0,"volume":650454,"delay":0,"ttmEps":-5.769904,"open":101.13,"prevYearClose":84.61,"prevWeekClose":104.1,"prevMonthClose":105.16,"prevQuarterClose":116.63,"fiveDayClose":108.08,"twentyDayClose":108.35,"sixtyDayClose":129.17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AXSM\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522039881","title":"Axsome Therapeutics announces FOCUS Phase 3 trial achieved primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522039881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522039881?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:57","pubTimestamp":1742929045,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (AXSM) announced that the FOCUS Phase 3 trial of solriamfetol in the treatment of attention deficit hyperactivity disorder achi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-announces-focus-phase-3-trial-achieved-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-announces-focus-phase-3-trial-achieved-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4505","AXSM","BK4007"],"gpt_icon":0},{"id":"2522885337","title":"Axsome Therapeutics’ Promising Phase III FOCUS Trial Results Boost Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522885337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522885337?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:35","pubTimestamp":1742916935,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on AXSM stock, giving a Buy rating today. Myles Minter’s rating is based on ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-promising-phase-iii-focus-trial-results-boost-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-promising-phase-iii-focus-trial-results-boost-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM","III"],"gpt_icon":0},{"id":"2522021437","title":"Axsome Therapeutics' Phase 3 Trial of Solriamfetol to Treat ADHD Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522021437","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522021437?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:45","pubTimestamp":1742903124,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics  said Tuesday that the phase 3 trial of solriamfetol as a potential treatment for attention deficit hyperactivity disorder achieved its primary and key secondary endpoints, demonstrating \"statistically significant\" improvement in symptoms and disease severity.The study met its primary endpoint of a statistically significant reduction in the Adult ADHD Investigator Symptom Rating Scale compared with placebo at week six. The study also achieved the key secondary endpoint of a significant reduction in overall ADHD disease severity, Axsome added.Solriamfetol was also well-tolerated in the study, with no serious adverse events reported, according to Axsome.Axsome Chief Executive Officer Herriot Tabuteau said the company plans to start a solriamfetol trial in pediatric patients this year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AXSM","BK4585","ADHD","BK4007","BK4505","ABVC","BK4139"],"gpt_icon":0},{"id":"2522021451","title":"BRIEF-Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522021451","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522021451?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:45","pubTimestamp":1742903113,"startTime":"0","endTime":"0","summary":"BRIEF-Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary EndpointMarch 25 (Reuters) - Axsome Therapeutics","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q804P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","BK4007","AXSM"],"gpt_icon":0},{"id":"2522023160","title":"Axsome Therapeutics' ADHD drug meets main goal in late-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522023160","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522023160?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:09","pubTimestamp":1742900972,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics' ADHD drug meets main goal in late-stage studyMarch 25  - Axsome Therapeutics AXSM.O said on Tuesday its experimental drug to treat attention deficit hyperactivity disorder  met the main goal in a late-stage study.    ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL3N3Q80OP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4505","BK4007","AXSM"],"gpt_icon":0},{"id":"2522702382","title":"Axsome Therapeutics Inc: Well Tolerated With Safety Profile Generally Consistent With Prior Solriamfetol Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2522702382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522702382?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:03","pubTimestamp":1742900595,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q804P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AXSM","BK4505","BK4007","BK4585"],"gpt_icon":0},{"id":"2522028022","title":"Axsome Therapeutics Announces Focus Phase 3 Trial of Solriamfetol in Adults With Attention Deficit Hyperactivity Disorder (Adhd) Achieves Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522028022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522028022?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:03","pubTimestamp":1742900595,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q804P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AXSM","BK4585","BK4505","BK4007"],"gpt_icon":0},{"id":"2522023849","title":"Axsome Therapeutics Inc: Statistically Significant Reduction in Overall Adhd Disease Severity as Measured by CGI-S Score Compared to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2522023849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522023849?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:03","pubTimestamp":1742900595,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q804P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","AXSM","BK4585","BK4007"],"gpt_icon":0},{"id":"2522033331","title":"Strong Growth and Positive Outlook for Axsome Therapeutics’ Auvelity Drives Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522033331","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522033331?lang=en_us&edition=fundamental","pubTime":"2025-03-25 08:25","pubTimestamp":1742862325,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on AXSM stock, giving a Buy rating on March 21. Graig Suvannavejh h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strong-growth-and-positive-outlook-for-axsome-therapeutics-auvelity-drives-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strong-growth-and-positive-outlook-for-axsome-therapeutics-auvelity-drives-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM"],"gpt_icon":0},{"id":"2521785870","title":"Strong Market Performance and Growth Potential of Auvelity Drives Positive Outlook for Axsome Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2521785870","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521785870?lang=en_us&edition=fundamental","pubTime":"2025-03-24 02:15","pubTimestamp":1742753723,"startTime":"0","endTime":"0","summary":"Vikram Purohit, an analyst from Morgan Stanley, maintained the Buy rating on Axsome Therapeutics (AXSM – Research Report). The associated price tar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strong-market-performance-and-growth-potential-of-auvelity-drives-positive-outlook-for-axsome-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strong-market-performance-and-growth-potential-of-auvelity-drives-positive-outlook-for-axsome-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0106831901.USD","BK4581","BK4516","LU0106261372.USD","LU0314104364.USD","LU0098860793.USD","LU1668664300.SGD","LU0225283273.USD","LU0267386448.USD","LU2023251221.USD","LU1720051108.HKD","LU2347655156.SGD","BK4585","LU1363072403.SGD","LU1989772923.USD","LU2133065610.SGD","LU2357305700.SGD","LU0158827781.USD","BK4588","LU1548497426.USD","LU0320765646.SGD","LU1989772840.SGD","LU2089283258.USD","LU2089284900.SGD","BK4127","IE00BKVL7J92.USD","LU0795875086.SGD","LU2028103732.USD","LU1162221912.USD","LU2111349929.HKD","LU2271345857.HKD","BK4534","BK4504","LU1732799900.SGD","BK4505","AXSM","LU0795875169.SGD","LU0971096721.USD","LU1720051017.SGD","LU0006306889.USD","IE00BZ1G4Q59.USD","LU0158827948.USD","LU1074936037.SGD","LU1732800096.USD","LU0912757837.SGD","BK4007"],"gpt_icon":0},{"id":"2520199470","title":"HRMY Down 10.8% in Six Months: How Should You Play the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520199470","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520199470?lang=en_us&edition=fundamental","pubTime":"2025-03-20 00:14","pubTimestamp":1742400840,"startTime":"0","endTime":"0","summary":"Shares of Harmony Biosciences HRMY have lost 10.8% in the past six months compared with the industry’s decline of 9.7%. The stock has also underperformed the S&P 500 index during this timeframe.The stock was hit last month after the company announced that it received a Refusal to File  letter from the FDA for pitolisant for the treatment of excessive daytime sleepiness  in adult patients with idiopathic hypersomnia .Nonetheless, the fourth-quarter results reported on Feb. 25 were better-than-expected and shares recovered a bit.Let’s dig deeper and understand the company’s strengths and weaknesses in detail to understand how to play the stock in such a scenario.HRMY’s Efforts to Expand Wakix’s Label Suffer Setback. The company was looking to expand the drug’s label for EDS in adult patients with IH. The supplemental new drug application  for pitolisant in IH was submitted in the fourth quarter based on data from the INTUNE study and additional sources.The company targets to initiate a p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hrmy-down-10-8-six-161400902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["JAZZ","AXSM","BK4085","HRMY","BK4510","IE00BN0W2T93.GBP","LU0823416689.USD","BK4563","IE00BN0W2W23.USD","LU0320765992.SGD","LU0109394709.USD","BK4585","BK4532","BK4505","FXS","IH","BK4007","LU0889565916.HKD","BK4533","IE00BN0W2V16.EUR"],"gpt_icon":0},{"id":"2520938623","title":"Axsome Therapeutics' (NASDAQ:AXSM) growing losses don't faze investors as the stock rises 5.8% this past week","url":"https://stock-news.laohu8.com/highlight/detail?id=2520938623","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520938623?lang=en_us&edition=fundamental","pubTime":"2025-03-18 23:32","pubTimestamp":1742311922,"startTime":"0","endTime":"0","summary":"It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/axsome-therapeutics-nasdaqaxsm-growing-losses-dont-faze-inve-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4585","LU2210150020.SGD","NDAQ","AXSM","IE00B3QW5Z07.USD","BK4588","USJW.SI","NVIW.SI","IE00BGHQF748.EUR","PSQ","QLD","QID","NQmain","LU2210149790.SGD","BK4505","TSYW.SI","USAW.SI","BK4112",".IXIC","BK4007","LU2095319765.USD","TQQQ","MNQmain","SQQQ"],"gpt_icon":1},{"id":"2519633827","title":"Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519633827","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519633827?lang=en_us&edition=fundamental","pubTime":"2025-03-14 22:55","pubTimestamp":1741964100,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics’ AXSM Auvelity  was launched in the United States in 2022 for the treatment of major depressive disorder , making it the first approved drug in the company’s portfolio.Auvelity generated sales worth $291.4 million in 2024, reflecting an increase of 124% year over year in the United States. Sales of the drug are being driven by an increase in unit sales volume and the momentum is likely to continue in 2025.Axsome is also working to expand the label of Auvelity for the larger commercial opportunity in other central nervous system  disorders like Alzheimer’s disease  agitation and smoking cessation.The successful development and potential approval of Auvelity in additional indications will help the drug address a broader patient population and drive sales further.Axsome is evaluating Sunosi in separate phase III studies for treating attention deficit hyperactivity disorder , MDD, binge eating disorder and excessive sleepiness associated with shift work disorder.Top-lin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/auvelity-other-drugs-aid-axsms-145500596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","LU2065171402.SGD","LU2065169927.USD","BK4007","IE00BN0W2V16.EUR","JAZZ","BK4533","LU0320765992.SGD","ACAD","LU0109394709.USD","ADHD","AXSM","BK4135","IE00BN0W2T93.GBP","ABVC","LU2065171311.SGD","BK4585","LU2065170008.USD","CNS","BK4139","IE00BN0W2W23.USD","LU0823416689.USD","BK4505","LU0889565916.HKD"],"gpt_icon":0},{"id":"2519386531","title":"Is Axsome Therapeutics, Inc. (AXSM) the Best Performing Growth Stock in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519386531","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519386531?lang=en_us&edition=fundamental","pubTime":"2025-03-14 22:32","pubTimestamp":1741962735,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at where Axsome Therapeutics, Inc.  stands against other best performing growth stocks in 2025.Heavy AI investments and the tariffs uncertainty have been putting pressure on the technology and growth sector. While some analysts are giving caution to stay away from growth and tech stocks Doug Clinton, Intelligent Alpha founder and CEO remains bullish on tech and growth stocks. He joined CNBC on February 12 for an interview. He noted that moving past the DeepSeek incident the sector has stabilized and he remains bullish on the tech sector. Some of the positive news for the sector as highlighted by Clinton includes hyper-scalers showing earnings growth, moreover, CEOs from the AI industry have indicated that the capital expenditure boom will continue.To curate the list of 10 best-performing growth stocks in 2025 we used the Finviz stock screener. Using the screener we aggr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axsome-therapeutics-inc-axsm-best-143215845.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","QLD","USAW.SI","AXSM","PSQ","QID","TSYW.SI","USJW.SI","NQmain",".IXIC","NVIW.SI","BK4585","TQQQ","SQQQ","BK4505","MNQmain"],"gpt_icon":1},{"id":"2517191949","title":"AXSM Settles Sunosi Patent Litigation With Hikma Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2517191949","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517191949?lang=en_us&edition=fundamental","pubTime":"2025-03-06 23:27","pubTimestamp":1741274820,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics AXSM announced that it has entered into a settlement agreement with Hikma Pharmaceuticals related to patents for its narcolepsy drug, Sunosi .The settlement agreement resolves the patent litigation brought by Axsome on Hikma for submitting an abbreviated new drug application to the FDA, seeking marketing approval for a generic version of Sunosi in the United States. The patent litigation is pending in the United States District Court for the District of New Jersey.Axsome acquired U.S. rights to Sunosi from Jazz Pharmaceuticals JAZZ in May 2022. It began selling Sunosi in the U.S. market in May 2022 and in certain international markets in November 2022.Jazz had received approval for Sunosi as a treatment for narcolepsy in 2019.JAZZ is entitled to receive a high single-digit royalty from Axsome on net sales of Sunosi in the United States. AXSM out-licensed its ex-U.S. marketing rights of Sunosi to Pharmanovia in February 2023.In the past year, shares of Axsome have ra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axsm-settles-sunosi-patent-litigation-152700923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RIGL","LU0823416689.USD","BK4505","IE00BN0W2T93.GBP","BK4139","BK4533","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","ANIP","LU0320765992.SGD","LU0109394709.USD","BK4532","LU0889565916.HKD","BK4007","JAZZ","ABVC","AXSM","BK4585","ADHD"],"gpt_icon":0},{"id":"2517154461","title":"TD Cowen Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154461?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:57","pubTimestamp":1741265823,"startTime":"0","endTime":"0","summary":"In a report released today, Joseph Thome from TD Cowen maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report), with a price target...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-axsome-therapeutics-axsm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-axsome-therapeutics-axsm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM","TD","COWN"],"gpt_icon":0},{"id":"2517154425","title":"Axsome Therapeutics Price Target Maintained With a $200.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154425","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154425?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:46","pubTimestamp":1741265160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AXSM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2025 07:46 ET (12:46 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM"],"gpt_icon":0},{"id":"2517671155","title":"Axsome Therapeutics: Strategic Developments and Market Exclusivity Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517671155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517671155?lang=en_us&edition=fundamental","pubTime":"2025-03-06 19:26","pubTimestamp":1741260365,"startTime":"0","endTime":"0","summary":"In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Axsome Therapeutics (AXSM – Research Report), with a pric...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-strategic-developments-and-market-exclusivity-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-strategic-developments-and-market-exclusivity-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM"],"gpt_icon":0},{"id":"2517792698","title":"Axsome Therapeutics management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2517792698","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517792698?lang=en_us&edition=fundamental","pubTime":"2025-03-06 04:11","pubTimestamp":1741205466,"startTime":"0","endTime":"0","summary":"Meeting to be held in New York on March 6 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving bre...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-management-to-meet-with-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-management-to-meet-with-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","AXSM","BK4585","BK4007"],"gpt_icon":0},{"id":"2517919070","title":"Axsome Therapeutics Resolves Sunosi Patent Case With Hikma","url":"https://stock-news.laohu8.com/highlight/detail?id=2517919070","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517919070?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:06","pubTimestamp":1741179964,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics  said Wednesday it has reached a settlement with Hikma Pharmaceuticals resolving a patent dispute over its treatment Sunosi The dispute arose after Hikma filed an abbreviated new drug application seeking Food and Drug Administration approval to produce a generic version of Sunosi, the company said.As part of the agreement, Axsome said it will grant Hikma a license to launch its generic version no earlier than March 1, 2040, or Sept. 1, 2040, if pediatric exclusivity is granted, pending regulatory approval.Axsome said the settlement will be submitted for review by the US Federal Trade Commission and the Department of Justice.The company said similar patent litigation against other parties related to Sunosi remains pending in the US District Court for the District of New Jersey.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","AXSM","BK4505","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AXSM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-05","symbol":"AXSM","fiscalQuarterEnding":"2025/03","expectedEps":-1.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746417600000,"reportTimeType":"pre","actualEps":-0.8},{"market":"US","date":"2025-02-18","symbol":"AXSM","fiscalQuarterEnding":"2024/12","expectedEps":-0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739854800000,"reportTimeType":"pre","actualEps":-0.96},{"market":"US","date":"2025-01-13","symbol":"AXSM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-12","symbol":"AXSM","fiscalQuarterEnding":"2024/09","expectedEps":-1.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.34},{"market":"US","date":"2024-08-05","symbol":"AXSM","fiscalQuarterEnding":"2024/06","expectedEps":-1.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"pre","actualEps":-1.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AXSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AXSM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.6316,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6316,"analysts":19,"updateTime":1749528000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AXSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AXSM","date":"2025-06-18","current":-18.027824,"percent":0.439935,"low":-46.566543,"twenty":-21.978884,"median":-16.742979,"eighty":-12.087351,"high":-6.009438,"avg":-18.013341,"sd":7.388965,"marketCap":5016638684},"quantilePoints":[{"date":"2020-06-26","current":-46.539419,"twenty":-23.453022,"median":-9.194644,"eighty":-3.347892,"marketCap":3180745235},{"date":"2020-07-02","current":-43.924662,"twenty":-23.537303,"median":-9.195895,"eighty":-3.355422,"marketCap":3002039185},{"date":"2020-07-10","current":-45.047597,"twenty":-23.575997,"median":-9.252351,"eighty":-3.360692,"marketCap":3078786389},{"date":"2020-07-17","current":-44.293549,"twenty":-23.688243,"median":-9.27672,"eighty":-3.360692,"marketCap":3027250827},{"date":"2020-07-24","current":-41.960882,"twenty":-23.79365,"median":-9.359006,"eighty":-3.361445,"marketCap":2867824268},{"date":"2020-07-31","current":-38.695148,"twenty":-23.90843,"median":-9.369936,"eighty":-3.364772,"marketCap":2644627085},{"date":"2020-08-07","current":-42.351468,"twenty":-24.001264,"median":-9.445345,"eighty":-3.367789,"marketCap":2894518948},{"date":"2020-08-14","current":-31.085393,"twenty":-24.144138,"median":-9.496431,"eighty":-3.374808,"marketCap":2945457014},{"date":"2020-08-21","current":-30.522708,"twenty":-24.239696,"median":-9.535186,"eighty":-3.37804,"marketCap":2892140513},{"date":"2020-08-28","current":-29.987567,"twenty":-24.493059,"median":-9.615634,"eighty":-3.390967,"marketCap":2841433911},{"date":"2020-09-04","current":-26.890832,"twenty":-24.785116,"median":-9.672397,"eighty":-3.390967,"marketCap":2548006738},{"date":"2020-09-11","current":-28.736281,"twenty":-25.060244,"median":-9.751865,"eighty":-3.390967,"marketCap":2722869945},{"date":"2020-09-18","current":-32.12813,"twenty":-25.208723,"median":-9.865391,"eighty":-3.390967,"marketCap":3044260318},{"date":"2020-09-25","current":-30.30629,"twenty":-26.023431,"median":-10.00765,"eighty":-3.390967,"marketCap":2871634167},{"date":"2020-10-02","current":-27.740762,"twenty":-26.53307,"median":-10.090701,"eighty":-3.390967,"marketCap":2628540753},{"date":"2020-10-09","current":-29.354054,"twenty":-27.382689,"median":-10.228673,"eighty":-3.416217,"marketCap":2781406243},{"date":"2020-10-16","current":-29.015656,"twenty":-28.035876,"median":-10.330949,"eighty":-3.42888,"marketCap":2749341774},{"date":"2020-10-23","current":-28.087029,"twenty":-28.082185,"median":-10.398962,"eighty":-3.42888,"marketCap":2661350907},{"date":"2020-10-30","current":-26.092055,"twenty":-28.035876,"median":-10.444372,"eighty":-3.440834,"marketCap":2472319678},{"date":"2020-11-06","current":-25.564895,"twenty":-28.035876,"median":-10.489783,"eighty":-3.440834,"marketCap":2519239799},{"date":"2020-11-13","current":-28.111531,"twenty":-28.035876,"median":-10.687485,"eighty":-3.440834,"marketCap":2770192830},{"date":"2020-11-20","current":-27.452134,"twenty":-28.082185,"median":-10.932533,"eighty":-3.440834,"marketCap":2705213920},{"date":"2020-11-27","current":-28.490495,"twenty":-28.083154,"median":-11.119611,"eighty":-3.45465,"marketCap":2807537031},{"date":"2020-12-04","current":-30.339838,"twenty":-28.091929,"median":-11.258606,"eighty":-3.484182,"marketCap":2989776732},{"date":"2020-12-11","current":-30.059405,"twenty":-28.419132,"median":-11.329873,"eighty":-3.490702,"marketCap":2962142023},{"date":"2020-12-18","current":-29.661493,"twenty":-28.560787,"median":-11.457113,"eighty":-3.490702,"marketCap":2922930612},{"date":"2020-12-24","current":-32.177812,"twenty":-28.75014,"median":-11.558574,"eighty":-3.490702,"marketCap":3170896106},{"date":"2020-12-31","current":-30.874177,"twenty":-28.947976,"median":-11.582928,"eighty":-3.498176,"marketCap":3042432055},{"date":"2021-01-08","current":-29.449273,"twenty":-29.095272,"median":-11.714853,"eighty":-3.516148,"marketCap":2902017859},{"date":"2021-01-15","current":-29.085468,"twenty":-29.198234,"median":-11.798821,"eighty":-3.532002,"marketCap":2866167426},{"date":"2021-01-22","current":-28.289644,"twenty":-29.165155,"median":-11.860918,"eighty":-3.540569,"marketCap":2787744604},{"date":"2021-01-29","current":-25.803642,"twenty":-29.16126,"median":-11.953582,"eighty":-3.54161,"marketCap":2542766646},{"date":"2021-02-05","current":-28.517022,"twenty":-29.142048,"median":-12.324236,"eighty":-3.552989,"marketCap":2810151125},{"date":"2021-02-12","current":-28.282065,"twenty":-29.117759,"median":-12.416899,"eighty":-3.583568,"marketCap":2786997720},{"date":"2021-02-19","current":-27.38771,"twenty":-29.085468,"median":-12.602226,"eighty":-3.590436,"marketCap":2698865406},{"date":"2021-02-26","current":-25.526998,"twenty":-29.049432,"median":-12.694889,"eighty":-3.590436,"marketCap":2515505379},{"date":"2021-03-05","current":-23.635339,"twenty":-29.023526,"median":-12.694889,"eighty":-3.613962,"marketCap":2432090525},{"date":"2021-03-12","current":-24.169696,"twenty":-29.015656,"median":-12.940357,"eighty":-3.730855,"marketCap":2487076269},{"date":"2021-03-19","current":-23.482665,"twenty":-28.846457,"median":-13.52886,"eighty":-3.760079,"marketCap":2416380312},{"date":"2021-03-26","current":-21.534258,"twenty":-28.838588,"median":-13.621523,"eighty":-3.76982,"marketCap":2215888076},{"date":"2021-04-01","current":-20.901753,"twenty":-28.78446,"median":-13.760518,"eighty":-3.76982,"marketCap":2150802910},{"date":"2021-04-09","current":-19.262328,"twenty":-28.770928,"median":-13.971843,"eighty":-3.76982,"marketCap":1982105151},{"date":"2021-04-16","current":-19.425907,"twenty":-28.764865,"median":-14.131173,"eighty":-3.800991,"marketCap":1998937521},{"date":"2021-04-23","current":-19.307504,"twenty":-28.757285,"median":-14.335102,"eighty":-3.816578,"marketCap":1986753718},{"date":"2021-04-30","current":-22.070934,"twenty":-28.740179,"median":-14.508939,"eighty":-3.818526,"marketCap":2271112305},{"date":"2021-05-07","current":-20.793258,"twenty":-28.736281,"median":-14.681183,"eighty":-3.818526,"marketCap":2139638718},{"date":"2021-05-14","current":-22.019873,"twenty":-28.701655,"median":-14.801134,"eighty":-3.818526,"marketCap":2194862183},{"date":"2021-05-21","current":-20.870256,"twenty":-28.655296,"median":-14.864222,"eighty":-3.826319,"marketCap":2080272494},{"date":"2021-05-28","current":-22.883028,"twenty":-28.636775,"median":-14.92072,"eighty":-3.83606,"marketCap":2280898376},{"date":"2021-06-04","current":-23.112951,"twenty":-28.62768,"median":-15.069857,"eighty":-3.849697,"marketCap":2303816314},{"date":"2021-06-11","current":-25.023953,"twenty":-28.565893,"median":-15.2723,"eighty":-3.85749,"marketCap":2494298192},{"date":"2021-06-18","current":-25.3858,"twenty":-28.525855,"median":-15.395896,"eighty":-3.892558,"marketCap":2530365766},{"date":"2021-06-25","current":-27.70388,"twenty":-28.520054,"median":-15.583979,"eighty":-3.962694,"marketCap":2761423665},{"date":"2021-07-02","current":-24.89203,"twenty":-28.501106,"median":-15.829585,"eighty":-4.001321,"marketCap":2481148555},{"date":"2021-07-09","current":-24.620645,"twenty":-28.488077,"median":-16.072993,"eighty":-4.020803,"marketCap":2454097874},{"date":"2021-07-16","current":-20.436794,"twenty":-28.467162,"median":-16.281692,"eighty":-4.296588,"marketCap":2037066545},{"date":"2021-07-23","current":-20.233255,"twenty":-28.441204,"median":-16.586109,"eighty":-4.680907,"marketCap":2016778535},{"date":"2021-07-30","current":-18.314715,"twenty":-28.433613,"median":-16.793478,"eighty":-4.685848,"marketCap":1825545250},{"date":"2021-08-06","current":-19.283408,"twenty":-28.418818,"median":-17.12943,"eighty":-4.706221,"marketCap":1922101152},{"date":"2021-08-13","current":-7.580584,"twenty":-28.417086,"median":-16.637241,"eighty":-4.716408,"marketCap":861409331},{"date":"2021-08-20","current":-7.149492,"twenty":-28.417086,"median":-16.132105,"eighty":-4.716408,"marketCap":812422798},{"date":"2021-08-27","current":-7.958618,"twenty":-28.417086,"median":-15.583979,"eighty":-4.716408,"marketCap":904366752},{"date":"2021-09-03","current":-8.850647,"twenty":-28.417086,"median":-15.2723,"eighty":-4.716408,"marketCap":1005731192},{"date":"2021-09-10","current":-9.082773,"twenty":-28.417086,"median":-14.928377,"eighty":-4.716408,"marketCap":1032108555},{"date":"2021-09-17","current":-9.855422,"twenty":-28.417086,"median":-14.839801,"eighty":-4.716408,"marketCap":1119907494},{"date":"2021-09-24","current":-11.075744,"twenty":-28.417086,"median":-14.51997,"eighty":-4.716408,"marketCap":1258577063},{"date":"2021-10-01","current":-11.36756,"twenty":-28.417086,"median":-14.177504,"eighty":-4.716408,"marketCap":1291737177},{"date":"2021-10-08","current":-10.677813,"twenty":-28.417086,"median":-13.899514,"eighty":-4.716408,"marketCap":1213358725},{"date":"2021-10-15","current":-13.297524,"twenty":-28.417086,"median":-13.602473,"eighty":-4.716408,"marketCap":1511046114},{"date":"2021-10-22","current":-13.297524,"twenty":-28.417086,"median":-13.469961,"eighty":-4.716408,"marketCap":1511046114},{"date":"2021-10-29","current":-12.76695,"twenty":-28.417086,"median":-13.144984,"eighty":-4.716408,"marketCap":1450754998},{"date":"2021-11-05","current":-13.330685,"twenty":-28.417086,"median":-13.115139,"eighty":-4.716408,"marketCap":1514814309},{"date":"2021-11-12","current":-11.782465,"twenty":-28.417086,"median":-12.97288,"eighty":-4.716408,"marketCap":1479777437},{"date":"2021-11-19","current":-10.744071,"twenty":-28.417086,"median":-12.694889,"eighty":-4.716408,"marketCap":1349364041},{"date":"2021-11-26","current":-11.080198,"twenty":-28.417086,"median":-12.602226,"eighty":-4.716408,"marketCap":1391578782},{"date":"2021-12-03","current":-9.675666,"twenty":-28.417086,"median":-12.509562,"eighty":-4.716408,"marketCap":1215181471},{"date":"2021-12-10","current":-9.94877,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1249480948},{"date":"2021-12-17","current":-10.594014,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1330518174},{"date":"2021-12-23","current":-11.539372,"twenty":-28.417086,"median":-12.235636,"eighty":-4.716408,"marketCap":1449247133},{"date":"2021-12-31","current":-11.338296,"twenty":-28.417086,"median":-11.768255,"eighty":-4.716408,"marketCap":1423993672},{"date":"2022-01-07","current":-9.876742,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1240434933},{"date":"2022-01-14","current":-8.583252,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1077983563},{"date":"2022-01-21","current":-7.114196,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":893482530},{"date":"2022-01-28","current":-7.898993,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":992046412},{"date":"2022-02-04","current":-8.616265,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1082129654},{"date":"2022-02-11","current":-9.621646,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1208396959},{"date":"2022-02-18","current":-8.874363,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1114544544},{"date":"2022-02-25","current":-8.460206,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1062529953},{"date":"2022-03-04","current":-8.825214,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1150834298},{"date":"2022-03-11","current":-9.674984,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1261646828},{"date":"2022-03-18","current":-9.916932,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1293197618},{"date":"2022-03-25","current":-10.433285,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1360531621},{"date":"2022-04-01","current":-12.95604,"twenty":-28.415355,"median":-11.795362,"eighty":-4.726594,"marketCap":1689506320},{"date":"2022-04-08","current":-12.00595,"twenty":-28.415355,"median":-12.224063,"eighty":-4.726594,"marketCap":1565611755},{"date":"2022-04-14","current":-10.875874,"twenty":-28.415355,"median":-12.224063,"eighty":-4.726594,"marketCap":1418246480},{"date":"2022-04-22","current":-11.667797,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1521515699},{"date":"2022-04-29","current":-9.47449,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1235501878},{"date":"2022-05-06","current":-8.242936,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1160402061},{"date":"2022-05-13","current":-7.712204,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1085688045},{"date":"2022-05-20","current":-8.74879,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1231613857},{"date":"2022-05-27","current":-7.314154,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1029652533},{"date":"2022-06-03","current":-7.057081,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":993462931},{"date":"2022-06-10","current":-6.730902,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":947544942},{"date":"2022-06-17","current":-6.272039,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":882948449},{"date":"2022-06-24","current":-6.761308,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":951825433},{"date":"2022-07-01","current":-11.233834,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1581446672},{"date":"2022-07-08","current":-12.604892,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1774457880},{"date":"2022-07-15","current":-12.076924,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1700132999},{"date":"2022-07-22","current":-11.142614,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1568605200},{"date":"2022-07-29","current":-10.667166,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1501673894},{"date":"2022-08-05","current":-12.007818,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1690404612},{"date":"2022-08-12","current":-12.438313,"twenty":-28.417086,"median":-12.604892,"eighty":-4.716408,"marketCap":1864871817},{"date":"2022-08-19","current":-16.008246,"twenty":-28.417086,"median":-12.734015,"eighty":-4.716408,"marketCap":2400110584},{"date":"2022-08-26","current":-19.19834,"twenty":-28.417086,"median":-13.012341,"eighty":-4.716408,"marketCap":2878400274},{"date":"2022-09-02","current":-18.014352,"twenty":-28.417086,"median":-13.144984,"eighty":-4.716408,"marketCap":2700885345},{"date":"2022-09-09","current":-17.751244,"twenty":-28.417086,"median":-13.297524,"eighty":-4.716408,"marketCap":2661437584},{"date":"2022-09-16","current":-16.93046,"twenty":-28.417086,"median":-13.546231,"eighty":-4.716408,"marketCap":2538377718},{"date":"2022-09-23","current":-14.373731,"twenty":-28.417086,"median":-13.785155,"eighty":-4.716408,"marketCap":2155048380},{"date":"2022-09-30","current":-12.760762,"twenty":-28.417086,"median":-13.785155,"eighty":-4.716408,"marketCap":1913216449},{"date":"2022-10-07","current":-13.103947,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1964670051},{"date":"2022-10-14","current":-13.7274,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":2058144096},{"date":"2022-10-21","current":-11.862761,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1778579522},{"date":"2022-10-28","current":-12.102991,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1814597044},{"date":"2022-11-04","current":-16.327026,"twenty":-28.417086,"median":-13.971843,"eighty":-4.716408,"marketCap":2447905134},{"date":"2022-11-11","current":-16.029117,"twenty":-28.417086,"median":-14.373731,"eighty":-4.767341,"marketCap":2562577819},{"date":"2022-11-18","current":-15.257677,"twenty":-28.417086,"median":-14.497908,"eighty":-4.79395,"marketCap":2439247519},{"date":"2022-11-25","current":-15.434239,"twenty":-28.417086,"median":-14.724173,"eighty":-4.898255,"marketCap":2467474524},{"date":"2022-12-02","current":-20.888648,"twenty":-28.417086,"median":-14.896404,"eighty":-4.898255,"marketCap":3339471857},{"date":"2022-12-09","current":-20.334515,"twenty":-28.417086,"median":-14.934267,"eighty":-4.898255,"marketCap":3250882487},{"date":"2022-12-16","current":-21.296099,"twenty":-28.417086,"median":-15.271259,"eighty":-4.898255,"marketCap":3404611100},{"date":"2022-12-23","current":-20.043867,"twenty":-28.417086,"median":-15.412018,"eighty":-4.898255,"marketCap":3204416493},{"date":"2022-12-30","current":-20.951124,"twenty":-28.417086,"median":-15.545609,"eighty":-4.898255,"marketCap":3349459875},{"date":"2023-01-06","current":-18.46839,"twenty":-28.417086,"median":-15.702202,"eighty":-6.20404,"marketCap":2952544754},{"date":"2023-01-13","current":-18.280963,"twenty":-28.417086,"median":-16.029117,"eighty":-6.567519,"marketCap":2922580702},{"date":"2023-01-20","current":-19.23983,"twenty":-28.417086,"median":-16.281692,"eighty":-6.731359,"marketCap":3075875054},{"date":"2023-01-27","current":-19.087715,"twenty":-28.417086,"median":-16.637241,"eighty":-6.946485,"marketCap":3051556403},{"date":"2023-02-03","current":-18.66125,"twenty":-28.417086,"median":-17.062014,"eighty":-7.089998,"marketCap":2983377329},{"date":"2023-02-10","current":-17.055894,"twenty":-28.417086,"median":-17.13163,"eighty":-7.187,"marketCap":2726728711},{"date":"2023-02-17","current":-18.096252,"twenty":-28.417086,"median":-17.237888,"eighty":-7.373862,"marketCap":2893050912},{"date":"2023-02-24","current":-16.583251,"twenty":-28.417086,"median":-17.237888,"eighty":-7.712635,"marketCap":2651167190},{"date":"2023-03-03","current":-15.180365,"twenty":-28.417086,"median":-17.237888,"eighty":-7.893661,"marketCap":2840757185},{"date":"2023-03-10","current":-13.578148,"twenty":-28.417086,"median":-17.237888,"eighty":-8.043265,"marketCap":2540928493},{"date":"2023-03-17","current":-14.589708,"twenty":-28.417086,"median":-17.237888,"eighty":-8.219199,"marketCap":2730225272},{"date":"2023-03-24","current":-14.408325,"twenty":-28.417086,"median":-17.237888,"eighty":-8.347465,"marketCap":2696282401},{"date":"2023-03-31","current":-14.343213,"twenty":-28.415355,"median":-17.237888,"eighty":-8.438189,"marketCap":2684097781},{"date":"2023-04-06","current":-13.582799,"twenty":-28.415355,"median":-17.237888,"eighty":-8.515067,"marketCap":2541798823},{"date":"2023-04-14","current":-15.126881,"twenty":-28.417086,"median":-17.237888,"eighty":-8.590342,"marketCap":2830748390},{"date":"2023-04-21","current":-16.577945,"twenty":-28.417086,"median":-17.237888,"eighty":-8.633548,"marketCap":3102291356},{"date":"2023-04-28","current":-16.560131,"twenty":-28.417086,"median":-17.237888,"eighty":-8.782049,"marketCap":3098957798},{"date":"2023-05-05","current":-16.557804,"twenty":-28.417086,"median":-17.237888,"eighty":-8.912326,"marketCap":3098522307},{"date":"2023-05-12","current":-21.39324,"twenty":-28.417086,"median":-17.328154,"eighty":-9.013947,"marketCap":3395527537},{"date":"2023-05-19","current":-21.103076,"twenty":-28.417086,"median":-17.513874,"eighty":-9.093997,"marketCap":3349472883},{"date":"2023-05-26","current":-18.692708,"twenty":-28.417086,"median":-17.629041,"eighty":-9.135139,"marketCap":2966900073},{"date":"2023-06-02","current":-19.97476,"twenty":-28.417086,"median":-17.77844,"eighty":-9.187407,"marketCap":3170386977},{"date":"2023-06-09","current":-20.655593,"twenty":-28.417086,"median":-17.924982,"eighty":-9.24781,"marketCap":3278448546},{"date":"2023-06-16","current":-23.233424,"twenty":-28.417086,"median":-18.014352,"eighty":-9.337052,"marketCap":3687601016},{"date":"2023-06-23","current":-24.803733,"twenty":-28.418818,"median":-18.297839,"eighty":-9.445345,"marketCap":3936839794},{"date":"2023-06-30","current":-20.073591,"twenty":-28.420549,"median":-18.46839,"eighty":-9.469338,"marketCap":3186073334},{"date":"2023-07-07","current":-20.290469,"twenty":-28.420549,"median":-18.576208,"eighty":-9.560131,"marketCap":3220496172},{"date":"2023-07-14","current":-20.040647,"twenty":-28.420549,"median":-18.698313,"eighty":-9.653222,"marketCap":3180844549},{"date":"2023-07-21","current":-20.433224,"twenty":-28.420549,"median":-18.862469,"eighty":-9.751865,"marketCap":3243154243},{"date":"2023-07-28","current":-21.245831,"twenty":-28.420549,"median":-18.946466,"eighty":-9.838866,"marketCap":3372130954},{"date":"2023-08-04","current":-20.666574,"twenty":-28.420549,"median":-19.022523,"eighty":-9.919098,"marketCap":3280191474},{"date":"2023-08-11","current":-18.037146,"twenty":-28.420549,"median":-19.022523,"eighty":-9.959731,"marketCap":3326963385},{"date":"2023-08-18","current":-17.717339,"twenty":-28.420549,"median":-19.022523,"eighty":-10.057126,"marketCap":3267974672},{"date":"2023-08-25","current":-19.290792,"twenty":-28.420549,"median":-19.061023,"eighty":-10.126968,"marketCap":3558199138},{"date":"2023-09-01","current":-20.672361,"twenty":-28.420549,"median":-19.094946,"eighty":-10.228966,"marketCap":3813030376},{"date":"2023-09-08","current":-20.830985,"twenty":-28.420549,"median":-19.19834,"eighty":-10.246301,"marketCap":3842288777},{"date":"2023-09-15","current":-19.495469,"twenty":-28.420549,"median":-19.262328,"eighty":-10.349328,"marketCap":3595951914},{"date":"2023-09-22","current":-19.119375,"twenty":-28.420549,"median":-19.262328,"eighty":-10.378868,"marketCap":3526581188},{"date":"2023-09-29","current":-18.692112,"twenty":-28.420549,"median":-19.262328,"eighty":-10.440043,"marketCap":3447772268},{"date":"2023-10-06","current":-17.23379,"twenty":-28.420549,"median":-19.262328,"eighty":-10.525456,"marketCap":3178783739},{"date":"2023-10-13","current":-17.016321,"twenty":-28.420549,"median":-19.262328,"eighty":-10.598456,"marketCap":3138671414},{"date":"2023-10-20","current":-16.438109,"twenty":-28.420549,"median":-19.262328,"eighty":-10.646711,"marketCap":3032019822},{"date":"2023-10-27","current":-16.386939,"twenty":-28.429835,"median":-19.282946,"eighty":-10.674305,"marketCap":3022581628},{"date":"2023-11-03","current":-16.476485,"twenty":-28.429835,"median":-19.282946,"eighty":-10.808289,"marketCap":3039098468},{"date":"2023-11-10","current":-14.081381,"twenty":-28.429835,"median":-19.282946,"eighty":-10.929836,"marketCap":2842011992},{"date":"2023-11-17","current":-13.999321,"twenty":-28.429835,"median":-19.282946,"eighty":-11.058288,"marketCap":2825450151},{"date":"2023-11-24","current":-14.665174,"twenty":-28.429835,"median":-19.282946,"eighty":-11.129652,"marketCap":2959837664},{"date":"2023-12-01","current":-15.814005,"twenty":-28.429835,"median":-19.282946,"eighty":-11.282106,"marketCap":3191703445},{"date":"2023-12-08","current":-16.46579,"twenty":-28.426058,"median":-19.282946,"eighty":-11.336853,"marketCap":3323251785},{"date":"2023-12-15","current":-17.178534,"twenty":-28.426058,"median":-19.282946,"eighty":-11.380162,"marketCap":3467103208},{"date":"2023-12-22","current":-16.993315,"twenty":-28.426058,"median":-19.282946,"eighty":-11.419937,"marketCap":3429720766},{"date":"2023-12-29","current":-18.667325,"twenty":-28.429835,"median":-19.282946,"eighty":-11.503011,"marketCap":3767582332},{"date":"2024-01-05","current":-19.222984,"twenty":-28.433613,"median":-19.282946,"eighty":-11.566713,"marketCap":3879729658},{"date":"2024-01-12","current":-20.245209,"twenty":-28.433613,"median":-19.306357,"eighty":-11.683287,"marketCap":4086042883},{"date":"2024-01-19","current":-19.811466,"twenty":-28.43739,"median":-19.389342,"eighty":-11.809472,"marketCap":3998501721},{"date":"2024-01-26","current":-21.239299,"twenty":-28.433613,"median":-19.465893,"eighty":-11.861401,"marketCap":4286677762},{"date":"2024-02-02","current":-21.909841,"twenty":-28.433613,"median":-19.601888,"eighty":-11.983144,"marketCap":4422011667},{"date":"2024-02-09","current":-22.432676,"twenty":-28.433613,"median":-19.675324,"eighty":-12.075057,"marketCap":4527534256},{"date":"2024-02-16","current":-21.912185,"twenty":-28.433613,"median":-19.76274,"eighty":-12.186969,"marketCap":4422484862},{"date":"2024-02-23","current":-15.927086,"twenty":-28.433613,"median":-19.76274,"eighty":-12.293238,"marketCap":3810364180},{"date":"2024-03-01","current":-16.115026,"twenty":-28.429835,"median":-19.739727,"eighty":-12.506682,"marketCap":3855326637},{"date":"2024-03-08","current":-14.265501,"twenty":-28.429835,"median":-19.739727,"eighty":-12.677006,"marketCap":3412849975},{"date":"2024-03-15","current":-13.810051,"twenty":-28.429835,"median":-19.739727,"eighty":-12.869437,"marketCap":3303888912},{"date":"2024-03-22","current":-16.012055,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3830691962},{"date":"2024-03-28","current":-15.677398,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3750629268},{"date":"2024-04-05","current":-14.291244,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3419008643},{"date":"2024-04-12","current":-14.204114,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3398163918},{"date":"2024-04-19","current":-13.014002,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3113443925},{"date":"2024-04-26","current":-14.16253,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3388215300},{"date":"2024-05-03","current":-14.728134,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3523529410},{"date":"2024-05-10","current":-11.807571,"twenty":-28.429835,"median":-19.701371,"eighty":-12.750063,"marketCap":3499492533},{"date":"2024-05-17","current":-12.395706,"twenty":-28.429835,"median":-19.649302,"eighty":-12.578012,"marketCap":3673802218},{"date":"2024-05-24","current":-11.887699,"twenty":-28.429835,"median":-19.525695,"eighty":-12.436014,"marketCap":3523240446},{"date":"2024-05-31","current":-11.892506,"twenty":-28.429835,"median":-19.442778,"eighty":-12.367228,"marketCap":3524665321},{"date":"2024-06-07","current":-11.980646,"twenty":-28.429835,"median":-19.343656,"eighty":-12.253794,"marketCap":3550788026},{"date":"2024-06-14","current":-11.620073,"twenty":-28.433613,"median":-19.298009,"eighty":-12.177866,"marketCap":3443922415},{"date":"2024-06-21","current":-12.047953,"twenty":-28.43739,"median":-19.272637,"eighty":-12.168336,"marketCap":3570736273},{"date":"2024-06-28","current":-12.834804,"twenty":-28.441192,"median":-19.23983,"eighty":-12.143826,"marketCap":3803940784},{"date":"2024-07-05","current":-12.854035,"twenty":-28.441192,"median":-19.19834,"eighty":-12.143826,"marketCap":3809640283},{"date":"2024-07-12","current":-13.549541,"twenty":-28.441192,"median":-19.087715,"eighty":-12.143826,"marketCap":4015772172},{"date":"2024-07-15","current":-13.273902,"twenty":-28.441192,"median":-19.07844,"eighty":-12.143826,"marketCap":3934079350},{"date":"2024-08-02","current":-13.783512,"twenty":-28.490495,"median":-18.952635,"eighty":-12.102991,"marketCap":4085116080},{"date":"2024-08-09","current":-13.223111,"twenty":-28.490495,"median":-18.859161,"eighty":-12.102991,"marketCap":4080017425},{"date":"2024-08-16","current":-13.318007,"twenty":-28.490495,"median":-18.73003,"eighty":-12.102991,"marketCap":4109297550},{"date":"2024-08-23","current":-13.551356,"twenty":-28.490495,"median":-18.673323,"eighty":-12.102991,"marketCap":4181297857},{"date":"2024-08-30","current":-13.862488,"twenty":-28.490495,"median":-18.56764,"eighty":-12.102991,"marketCap":4277298267},{"date":"2024-09-06","current":-14.57498,"twenty":-28.490495,"median":-18.506355,"eighty":-12.102991,"marketCap":4497139206},{"date":"2024-09-13","current":-14.273182,"twenty":-28.490495,"median":-18.365921,"eighty":-12.102991,"marketCap":4404018808},{"date":"2024-09-20","current":-14.672987,"twenty":-28.490495,"median":-18.269068,"eighty":-12.102991,"marketCap":4527379335},{"date":"2024-09-27","current":-13.944938,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":4302738376},{"date":"2024-10-04","current":-14.184509,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":4376658691},{"date":"2024-10-11","current":-12.924425,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":3987857031},{"date":"2024-10-18","current":-14.522087,"twenty":-28.490495,"median":-18.096122,"eighty":-12.102991,"marketCap":4480819136},{"date":"2024-10-25","current":-13.818929,"twenty":-28.490495,"median":-18.063615,"eighty":-12.102991,"marketCap":4263858210},{"date":"2024-10-31","current":-13.916936,"twenty":-28.490495,"median":-18.025749,"eighty":-12.102991,"marketCap":4294098339},{"date":"2024-11-08","current":-14.109838,"twenty":-28.4958,"median":-17.957834,"eighty":-12.097778,"marketCap":4353618593},{"date":"2024-11-15","current":-15.175127,"twenty":-28.4958,"median":-17.957834,"eighty":-12.097778,"marketCap":4718781551},{"date":"2024-11-22","current":-15.302924,"twenty":-28.4958,"median":-17.88108,"eighty":-12.097778,"marketCap":4758520699},{"date":"2024-11-29","current":-15.307599,"twenty":-28.4958,"median":-17.77844,"eighty":-12.097778,"marketCap":4759974570},{"date":"2024-12-06","current":-15.32786,"twenty":-28.449873,"median":-17.629041,"eighty":-12.097778,"marketCap":4766274679},{"date":"2024-12-13","current":-14.707576,"twenty":-28.320039,"median":-17.452847,"eighty":-12.097778,"marketCap":4573394423},{"date":"2024-12-20","current":-13.98599,"twenty":-28.091929,"median":-17.328154,"eighty":-12.097778,"marketCap":4349013622},{"date":"2024-12-27","current":-13.710136,"twenty":-27.950529,"median":-17.237888,"eighty":-12.097778,"marketCap":4263235216},{"date":"2025-01-03","current":-13.608833,"twenty":-27.778537,"median":-17.194427,"eighty":-12.097778,"marketCap":4231734672},{"date":"2025-01-10","current":-12.868545,"twenty":-27.620773,"median":-17.134813,"eighty":-12.092564,"marketCap":4001538386},{"date":"2025-01-17","current":-14.601598,"twenty":-27.401353,"median":-17.062407,"eighty":-12.092564,"marketCap":4540440007},{"date":"2025-01-24","current":-16.19127,"twenty":-27.316594,"median":-17.006543,"eighty":-12.092564,"marketCap":5034756242},{"date":"2025-01-31","current":-16.964286,"twenty":-27.062663,"median":-16.935586,"eighty":-12.092564,"marketCap":5275129627},{"date":"2025-02-07","current":-17.065589,"twenty":-26.869288,"median":-16.889297,"eighty":-12.092564,"marketCap":5306630172},{"date":"2025-02-14","current":-20.522345,"twenty":-26.613063,"median":-16.886581,"eighty":-12.092564,"marketCap":6381525671},{"date":"2025-02-21","current":-21.919439,"twenty":-26.428477,"median":-16.886581,"eighty":-12.092564,"marketCap":6295613527},{"date":"2025-02-28","current":-21.462713,"twenty":-26.259509,"median":-16.886581,"eighty":-12.092564,"marketCap":6164434593},{"date":"2025-03-07","current":-21.12314,"twenty":-25.773705,"median":-16.884764,"eighty":-12.087351,"marketCap":6066903787},{"date":"2025-03-14","current":-20.654529,"twenty":-25.461185,"median":-16.884764,"eighty":-12.087351,"marketCap":5932311274},{"date":"2025-03-21","current":-21.438943,"twenty":-25.440831,"median":-16.884764,"eighty":-12.087351,"marketCap":6157607436},{"date":"2025-03-28","current":-20.674904,"twenty":-25.12508,"median":-16.884764,"eighty":-12.087351,"marketCap":5938163123},{"date":"2025-04-04","current":-18.318267,"twenty":-24.742094,"median":-16.884764,"eighty":-12.087351,"marketCap":5261299329},{"date":"2025-04-11","current":-16.24008,"twenty":-24.602553,"median":-16.762118,"eighty":-12.092564,"marketCap":4664410796},{"date":"2025-04-17","current":-17.737597,"twenty":-24.358761,"median":-16.744642,"eighty":-12.092564,"marketCap":5094521651},{"date":"2025-04-25","current":-17.897196,"twenty":-23.915799,"median":-16.742979,"eighty":-12.087351,"marketCap":5140361130},{"date":"2025-05-02","current":-19.234219,"twenty":-23.617891,"median":-16.742979,"eighty":-12.087351,"marketCap":5524375578},{"date":"2025-05-09","current":-19.261265,"twenty":-23.314094,"median":-16.742979,"eighty":-12.087351,"marketCap":5359870693},{"date":"2025-05-16","current":-19.025033,"twenty":-23.105255,"median":-16.742979,"eighty":-12.087351,"marketCap":5294133855},{"date":"2025-05-23","current":-18.515782,"twenty":-22.831967,"median":-16.742979,"eighty":-12.087351,"marketCap":5152423687},{"date":"2025-05-30","current":-18.567239,"twenty":-22.597152,"median":-16.742979,"eighty":-12.087351,"marketCap":5166742833},{"date":"2025-06-06","current":-19.635423,"twenty":-22.218917,"median":-16.742979,"eighty":-12.087351,"marketCap":5463988550},{"date":"2025-06-13","current":-18.852917,"twenty":-22.04462,"median":-16.742979,"eighty":-12.087351,"marketCap":5246238781},{"date":"2025-06-18","current":-18.027824,"twenty":-21.978884,"median":-16.742979,"eighty":-12.087351,"marketCap":5016638684}],"updateTime":1750418343765}}}